Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel (K₊TP channel), composed of Kir6.2 and SUR1 subunits in pancreatic β-cells, serves as a key metabolic sensor that couples glucose levels to insulin secretion. At low glucose, open channels maintain hyperpolarization, suppressing Ca⁺² influx and insulin release; rising glucose boosts ATP/ADP ratios via glycolysis, closing channels to depolarize the membrane, activate voltage-gated Ca⁺² channels, and trigger insulin exocytosis in a biphasic manner. This glucose-stimulated insulin secretion (GSIS) mechanism is central to glucose homeostasis, with channel dysfunction implicated in diabetes: activating mutations cause neonatal diabetes by preventing closure, while impaired β-cell metabolism in type 2 diabetes reduces ATP generation and channel sensitivity. Therapeutically, sulfonylureas and meglitinides close K₊TP channels to enhance insulin release in diabetes management, though this risks hypoglycemia. Emerging insights highlight its role in oscillatory electrical activity and potential contributions to glucagon regulation in α-cells, underscoring its broad impact on islet function.
Channel closure by increased ATP/ADP ratio from glucose metabolism, leading to depolarization, voltage-gated Ca⁺² channel opening, and insulin granule exocytosis Pharmacological closure by sulfonylureas binding to SUR1 subunit, mimicking ATP effect to promote insulin release
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive potassium channel (KATP channel) (K₊TP channel).